Search
Monte Rosa Therapeutics Inc
GLUEAdd to Watchlist
16.520USD
-6.160-27.16%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.40BMarket Cap
LossP/E TTM
GLUE Financials
See Monte Rosa Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Monte Rosa Therapeutics Inc Earnings Date
Latest Release
May 7, 2026
EPS / Forecast
-0.45/-0.38
Revenue / Forecast
4.21M/10.88M
Period
FY2025 Earnings
Revenue(YoY)
123.67M
63.54%
EPS(YoY)
-0.46
52.73%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What is the total revenue of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its total revenue reached 123.67M, with a year-on-year change of 75.62M.
What are the current assets of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its current assets were 393.19M, with a year-on-year change of 4.17.
What are the total assets of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its total assets of Monte Rosa Therapeutics Inc were 448.66M, with a year-on-year change of 2.26.
What are the total liabilities of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its total liabilities of Monte Rosa Therapeutics Inc were 215.60M, with a year-on-year change of -0.09.
What is the total equity of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its total equity of Monte Rosa Therapeutics Inc was 233.06M, with a year-on-year change of 4.54.
What is the net operating income of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its net operating income of Monte Rosa Therapeutics Inc was -54.21M, with a year-on-year change of 33.17.
What is the net investment of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its net investment of Monte Rosa Therapeutics Inc was -101.83M, with a year-on-year change of -129.09.
What is the net financing of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its net financing of Monte Rosa Therapeutics Inc was 30.35M, with a year-on-year change of -69.31.
What is the Earnings Per Share (EPS) of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.46, with a year-on-year change of 52.73.
What is the net income of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its net income was -38.63M, with a year-on-year change of 46.87.
What is the net margin of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its net profit margin was -31.23, with a year-on-year change of 67.51.
What is the Return on Equity (ROE) of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -16.94, with a year-on-year change of 53.14.
What is the Return on Assets (ROA) of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -8.71, with a year-on-year change of 55.55.
What is the operating profit of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its operating profit was -54.21M, with a year-on-year change of 33.17.